UVA emergency room doctors are highlighting the virus’s underappreciated risks and potential drug interactions.
Recent Articles by
May 13, 2020
UVA Heath researcher Dr. William A. Petri, who is working on a vaccine for COVID-19, takes heart from history.
May 12, 2020
UVA found that fluvoxamine may prevent dangerous immune system overreactions, a major threat to COVID-19 patients.
May 11, 2020
UVA has pioneered an innovative new use for telemedicine in the battle against COVID-19, adapting it to improve patient care, conserve PPE and prevent infections.
May 06, 2020
New approaches under study at UVA could revolutionize treatment for conditions from Alzheimer’s to epilepsy to brain tumors – and even help repair the devastating damage caused by stroke.
May 04, 2020
The FDA issued emergency-use authorization allowing the use of remdesivir, an antiviral drug tested at UVA Health.
April 30, 2020
Remdesivir, an antiviral drug tested against COVID-19 at UVA Health and other sites, appeared to improve survival rates and speed recovery times.
April 29, 2020
Two of the School of Medicine’s leading researchers are teaming to take on something that neither may have attempted on their own: the riddle of spinal cord injuries.
April 15, 2020
An antioxidant produced during exercise may prevent or reduce the severity of acute respiratory distress syndrome. It may also offer a pathway to a new treatment.
April 08, 2020
An unexpected form of cellular cleanup in developing brains could play a role in conditions such as Alzheimer’s and Parkinson’s diseases and autism.